| Neurological features and outcome in COVID-19: dementia can predict severe disease M Ghaffari, H Ansari, N Beladimoghadam, SH Aghamiri, M Haghighi, ... Journal of NeuroVirology 27, 86-93, 2021 | 32 | 2021 |
| Coronavirus disease 2019 and stroke in Iran: a case series and effects on stroke admissions M Mehrpour, A Shuaib, M Farahani, HR Hatamabadi, Z Fatehi, M Ghaffari, ... International Journal of Stroke 16 (9), 1047-1052, 2021 | 26* | 2021 |
| The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy SH Aghamiri, K Komlakh, M Ghaffari Inflammopharmacology 30 (1), 51-60, 2022 | 20 | 2022 |
| Toll-like receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy SH Aghamiri, K Komlakh, M Ghaffari International Immunopharmacology 102, 108398, 2022 | 19 | 2022 |
| Effect of pregnancy and exclusive breastfeeding on multiple sclerosis relapse rate and degree of disability within two years after delivery M Ghiasian, M Nouri, AN Moghadasi, M Ghaffari Clinical Neurology and Neurosurgery 194, 105829, 2020 | 18 | 2020 |
| Epidemiology of familial multiple sclerosis in Iran: a national registry-based study Z Salehi, A Almasi-Hashiani, MA Sahraian, F Ashtari, SM Baghbanian, ... BMC neurology 22 (1), 76, 2022 | 15 | 2022 |
| COVID-19 vaccination willingness and acceptability in multiple sclerosis patients: a cross sectional study in Iran SM Nabavi, M Mehrabani, L Ghalichi, MA Nahayati, M Ghaffari, F Ashtari, ... Vaccines 10 (1), 135, 2022 | 12 | 2022 |
| Effects of a novel probiotic mixture on the modulation of brain and intestine Aquaporin-4 gene expression in rats exposed to Cadmium SS Rashed, M Ghaffari, NB Moghadam, MT Ebrahimi, Z Keshtmand Metabolic Brain Disease 37 (8), 2777-2782, 2022 | 6 | 2022 |
| Recurrent middle cerebral artery stroke caused by arterial thoracic outlet syndrome and coagulopathy SH Aghamiri, F Assarzadegan, M Ghaffari, NM Khorasani, BS Lima, ... Radiology Case Reports 17 (5), 1665-1669, 2022 | 6 | 2022 |
| Efficacy of mechanical thrombectomy in stroke patients with large vessel involvement SH Aghamiri, B Mansouri, M Mehrpour, SMH Karani, M Ghaffari, BS Lima, ... European Journal of Translational Myology 32 (2), 2022 | 3 | 2022 |
| MRI but not demographic or clinical characteristics differ between familial and sporadic MS cases NB Moghadam, M Ghaffari, SS Rashed, N Valaie, O Hesami, P Niloofar, ... Multiple Sclerosis and Related Disorders 56, 103235, 2021 | 3 | 2021 |
| Drug recommender system based on collaborative filtering for multiple sclerosis patients F Vakili, Z Vakili, M Kargari, M Ghaffari 2023 9th International Conference on Web Research (ICWR), 305-310, 2023 | 2 | 2023 |
| The effect of disease modifying drugs of multiple sclerosis on the effectiveness of BBIBP-CorV COVID19 vaccine M Ghaffari, N Beladimoghadam, SH Aghamiri, M Haghighi, A Javadi, ... Multiple Sclerosis and Related Disorders 59, 2022 | 2 | 2022 |
| Supervised Machine Learning Models for Multiple Sclerosis Relapse Probability Prognosis using Clinical Data F Vakili, Z Vakili, M Kargari, M Ghaffari 2023 9th International Conference on Web Research (ICWR), 150-155, 2023 | 1 | 2023 |
| Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment F Ghadiri, E Asadollahzadeh, Z Ebadi, MA Sahraian, A Azimi, S Navardi, ... Current Journal of Neurology 22 (1), 1, 2023 | 1 | 2023 |
| Progressive solitary sclerosis presented with diplopia: A case report MA Sahraian, M Ghiasian, AN Moghadasi, M Shafaei, M Ghaffari Multiple sclerosis and related disorders 28, 129-131, 2019 | 1 | 2019 |
| The investigation of the frequency of COVID-19 in patients with a history of stroke SH Aghamiri, AR Mafi, M Haghighi, M Ghaffari, A Karimzadeh Journal of Family Medicine and Primary Care 13 (5), 2078-2084, 2024 | | 2024 |
| The first study of real-world efficacy and safety of Natalizumab (Tysabri®) in Iran MA Shahrbaf, M Samimi, S Karimi, M Salari, M Ghaffari, S Yazdanbakhsh, ... Trends in Immunotherapy 8 (1), 3920, 2024 | | 2024 |
| Investigating the sleep quality and cognitive performance following combined aerobic-cognitive training in patients with multiple sclerosis S Farajnia, H Rajabi, M Ghaffari, N Blodi-moghadam, R Fayazmilani Journal of Sport and Exercise Physiology 16 (4), 67-79, 2024 | | 2024 |
| Effects of 6-Month Treatment with Dimethyl Fumarate (DMF) on Treatment Satisfaction and Work Improvement in Patients with Relapsing Remitting Multiple Sclerosis (RRMS)(Interim … R Abolfazli, MA Sahraian, V Shaygannejad, F Ashtari, ... Multiple Sclerosis and Related Disorders 80, 105195, 2023 | | 2023 |
Seyed Hossein AghamiriShahid Beheshti University of Medical Sciences在 sbmu.ac.ir 的电子邮件经过验证
